MaveriX Oncology
Palo Alto
About MaveriX Oncology
MaveriX is a globally-orientated biotechnology company focused on the discovery, development, and commercialization of targeted small-molecule cancer chemo-immunotherapies.Their technology approach leverages unexploited insights into cancer and immune cell metabolism within the tumor microenvironment which are common to all cancers.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $6.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2019)
- Website: maverixoncology.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Oncology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/maverix-oncology-23071 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.